EUCTR2012-005375-14-ES进行中（未招募）1 期
A prospective randomized clinical trial on 90Yttrium trans-arterialradio-Embolization (Therasphere) vs. standard of care (sorafenib)for the treatment of advanced Hepatocellular carcinoma (Hcc)with Portal Vein Thrombosis (PVT) - YES-P
ordion (Canada) Inc.0 个研究点目标入组 328 人开始时间: 2013年6月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 328
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients over 18 years of age, regardless of race or gender
- •- Advanced stage HCC with PVT and no extrahepatic metastases
- •- Child-Pugh A
- •- ECOG 0-1
- •- No contraindication to study treatment or procedures
- •- Not eligible for curative treatment including liver transplant
- •- No prior external beam radiation therapy
- •- No previous treatment with Sorafenib for more than 4 weeks during the 2 previous months; no prior sorafenib-related toxicity
- •- No previous conventional or drug eluting TACE unless it was performed at least 6 months prior to screening phase
- •- No history of organ allograft
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 164
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 164
排除标准
- •Not applicable
研究者
相似试验
进行中（未招募）
1 期
A prospective randomized clinical trial with the medical device Therasphere versus the drug sorafenib for the treatment of liver cancer (HCC) with a clot in the major liver (Portal Vein Thrombosis - PVT)Advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT)MedDRA version: 17.0Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 100000004864MedDRA version: 17.0Level: PTClassification code 10036206Term: Portal vein thrombosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2012-005375-14-BEBiocompatibles UK Ltd318
进行中（未招募）
1 期
A prospective randomized clinical trial with the medical device Therasphere versus the drug sorafenib for the treatment of liver cancer (HCC) with a clot in the major liver (Portal Vein Thrombosis - PVT)Advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT)MedDRA version: 18.0Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 100000004864MedDRA version: 18.0Level: PTClassification code 10036206Term: Portal vein thrombosisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2012-005375-14-GBBiocompatibles UK Ltd318
已完成
2 期
Comparing hormone profile and outcomes of ovulation triggering with GnRH and HGC in IVFFemale infertility.Female infertilityIRCT2015060222541N1Vice Chancellor of Research, Shiraz University of Medical Sciences232
尚未招募
1 期
A prospective randomized controlled trial for Yan's Jiangzhi Decoction Combined with atorvastatin in the treatment of dyslipidemia complicated with carotid atherosclerosisdyslipidemiacarotid atherosclerosisITMCTR2000003687Shanghai Tenth People's Hospital
招募中
2 期
dsyapereunia female sexual dysfunctioCTRI/2017/12/010947drnamratabbhagaje